Older HF patients initiated on ivabradine in UK: Quality of Life
Research type
Research Study
Full title
LIVE:LIFE oLder heart failure patients Initiated on iVabradinE in UK - quaLIty of liFE
IRAS ID
136603
Contact name
Paul R Kalra
Contact email
Sponsor organisation
Servier Laboratories (UK) Ltd.
Research summary
This study aims to follow 500 older patients with heart failure, who have been given ivabradine as part of their heart failure medication, for six months. Over that time, changes will be evaluated in:
-their Quality of life (using validated instruments)
-their ability to do things (using a 6 minute walking test)
-their heart rate and blood pressure
-their perception of their health
-their physician's perception of their health
-any changes to their medications (including the total number of medicines prescribed)In addition to the core data, at 18 months patients' vital status and medications will be assessed.
The study will be managed as an observational non-interventional study, i.e. all treatments will be given as usual, by their usual care team, with no additional procedures that would not normally be given as part of Best Practice
REC name
North East - Newcastle & North Tyneside 2 Research Ethics Committee
REC reference
13/NE/0345
Date of REC Opinion
14 Nov 2013
REC opinion
Favourable Opinion